Biotricity
成立一年
2014階段
首次公開募股 |上市首次公開募股日期
2/4/2016市值
0.15 bBiotricity產品視頻
與Biotricity?
確保您的公司和產品在我們的平台上得到準確的展示。
Biotricity的產品和差異化
Bioflux
實時心髒監護和雲係統,一體式解決方案,內置蜂窩技術
包含Biotricity的專家收藏
專家收藏是由分析師策劃的列表,突出了你在最重要的技術領域需要了解的公司。
Biotricity包含在5專家收藏,包括醫療設備.
醫療設備
11721件
開發醫療設備的公司(根據IMDRF對“醫療設備”的定義)。包括軟件、實驗室開發的測試(LDTs)和組合產品。*盡可能定期更新列。
數字醫療
13023件
為生活方式、健康或健康相關目的吸引消費者的技術、平台和係統;捕獲、存儲或傳輸健康數據;和/或支持生命科學和臨床操作。(DiME、DTA、HealthXL和NODE.Health)
遠程醫療
2856件
開發、提供或使用電子和電信技術以促進遠距離提供健康和保健服務的公司。*盡可能定期更新欄目;優先考慮獲得最多和/或最近融資的公司。
運行狀況監視和診斷
842件
公司提供的產品可以幫助遠距離評估患者的健康狀況。標記為# remotemmonitoring & diagnostics
它的健康
8881件
最新的Biotricity新聞
2023年1月13日
主要參與者:XinRay Systems, 112 Motion b.v., Varian Medical Systems, Inc., Bellabeat, Hitachi, Ltd., Biotricity, Aparito Ltd., Apple Inc., Bloomlife, MC10, NUVO Inc., Abbott, Medtronic, Koninklijke Philips N.V.等。預計到2022年,妊娠紋最小化產品將成為增長最快的細分市場。產品包括豐胸霜、縮小妊娠紋、緊致乳液、身體重塑凝膠等。妊娠紋最小化細分市場預計將在預測期內見證最高的增長率。這部分的主導地位歸因於將妊娠紋最小化劑作為預防措施的高使用率。由於預測期內孕期護理意識的提高,預計市場也將增長。預計到2022年,醫院藥房將成為增長最快的部門。分銷渠道部分包括心血管疾病、癌症、免疫疾病、神經疾病和其他疾病。醫院藥房部門預計將在預測期內見證最高的增長率。由於出生率激增,醫院藥房部門占據了最大的份額,婦產醫院通常有一個全天候開放的藥房,由注冊藥劑師提供必要的藥物。 In this segment, the growth is being fueled by the increasing demand for pregnancy-care products such as stretch mark minimizers. Regional Analysis The regional analysis provides a detailed perception of the key regions and the countries. Some of the key countries analyzed for the pregnancy care products market include the US, Canada, Mexico, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, Brazil, Peru, UAE, South Africa, and Saudi Arabia. The North American region witnessed a major share. It is projected that the North American pregnancy products market will dominate the market growth due to high awareness about pregnancy products and increasing personal care expenditures. Moreover, there is a growing awareness and acceptance of pregnancy products in this region, such as stretch mark minimizers, which is contributing to the growth of this region. Country Analysis Germany Germany's pregnancy care products market size was valued at USD 2.07 billion in 2021 and is expected to reach USD 3.24 billion by 2029, at a CAGR of 5.8% from 2023 to 2030. Market penetration, marketing initiatives, and per capita expenditure are some of the factors contributing to the country’s higher rankings in the pregnancy care products market. China China’s pregnancy care products market size was valued at USD 2.21 billion in 2021 and is expected to reach USD 3.5 billion by 2029, at a CAGR of 6.1% from 2023 to 2030. China has a large population base, which makes the customer base for these products much larger, as disposable incomes increase, the region has observed an increase in customer buying behaviour. As companies strive to increase awareness levels, aggressive marketing is also driving growth. India India’s pregnancy care products market size was valued at USD 1.7 billion in 2021 and is expected to reach USD 2.7 billion by 2029, at a CAGR of 6% from 2023 to 2030. Pregnancy care product demand is soaring, disposable income is increasing, the birth rate is rising, and more would-be parents have become aware of the benefits of pregnancy care products. Covid-19 Impact Covid-19 had a major impact on almost all industries, such as electronics, semiconductors, manufacturing, automobile, etc. However, several companies operating in the technology sector have seen increased revenue due to significant changes in consumer preferences toward technological services. In addition, the pandemic has led to significant growth in technology across developing and developed countries. Furthermore, the growth of this market is mainly driven owing to the increase due to the rising awareness about proper healthcare during pregnancy, propelling the growth of the market across the countries. Buy Now Full Report @ https://greyviews.com/checkout/376/single_user_license Contact Us
Biotricity常見問題
Biotricity是什麼時候成立的?
Biotricity成立於2014年。
Biotricity的總部在哪裏?
Biotricity總部位於Redwood Shores Pkwy 203號,Suite 600, Redwood City。
Biotricity的最新一輪融資是什麼?
Biotricity的最新一輪融資是IPO。
誰是Biotricity的投資者?
Biotricity的投資者包括MetaSolutions公司。
誰是Biotricity的競爭對手?
Biotricity的競爭對手包括Healionics、Lumenis、BioTelemetry、nContact Surgical、Shaser等13家公司。
Biotricity提供什麼產品?
Biotricity的產品包括Bioflux等。
比較Biotricity和競爭對手
C2C是一家醫療器械公司,開發了一係列醫療器械。
Tursiop Technologies Llc是一家醫療設備公司。它開發了Tt1通用線圈用於成像機。
ES血管有限公司開發了第一個用於血管內手術的外科吻合器。這些設備旨在通過縮短操作時間,簡化和潛在地提高最常見的血管幹預的安全性來改變血管外科。該公司目前正在開發開放式AAA、血管內AAA和Femoro-Pop旁路手術三個產品線。該公司的首批產品預計將於2008年進入市場。Snapshotn由Shifrin教授與來自美國和歐洲的工程師和領先的血管外科醫生團隊於2000年在以色列創立;n開發了一種有史以來的血管吻合器技術,用於將合成移植物吻合器固定到主動脈
用於治療嚴重胃腸疾病的醫療器械
Gaymar Industries是專業醫療設備製造商
Spineworks Medical, Inc.設計和製造用於脊柱手術的醫療設備。
為您的團隊發現正確的解決方案
CB I188bet游戏nsights技術市場情報平台分析供應商、產品、合作夥伴和專利的數百萬個數據點,幫助您的團隊找到他們的下一個技術解決方案。